These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ET block and the neointima: not the B, that is the answer. Coleman HA; Parkington HC Cardiovasc Res; 2012 Jul; 95(1):1-2. PubMed ID: 22637749 [No Abstract] [Full Text] [Related]
8. Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury. Fuseya T; Furuhashi M; Matsumoto M; Watanabe Y; Hoshina K; Mita T; Ishimura S; Tanaka M; Miura T J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903937 [TBL] [Abstract][Full Text] [Related]
9. New endoplasmic reticulum stress regulator, Gipie, regulates the survival of vascular smooth muscle cells and the neointima formation after vascular injury. Noda T; Maeda K; Hayano S; Asai N; Enomoto A; Takahashi M; Murohara T Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1246-53. PubMed ID: 25792451 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury. Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M Eur J Pharmacol; 2018 Feb; 820():222-228. PubMed ID: 29269019 [TBL] [Abstract][Full Text] [Related]
11. Distinct Differences on Neointima Formation in Immunodeficient and Humanized Mice after Carotid or Femoral Arterial Injury. Moser J; van Ark J; van Dijk MC; Greiner DL; Shultz LD; van Goor H; Hillebrands JL Sci Rep; 2016 Oct; 6():35387. PubMed ID: 27759053 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of adenosine kinase inhibition in vascular disease. Tual-Chalot S; Stellos K Cardiovasc Res; 2021 Jan; 117(2):354-356. PubMed ID: 32533148 [No Abstract] [Full Text] [Related]
13. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice. Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511 [TBL] [Abstract][Full Text] [Related]
15. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738 [TBL] [Abstract][Full Text] [Related]